Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool
Loss of Y chromosome in men could be early warning sign of cancer
B cells may help predict risk of colitis from immunotherapy
Researchers uncover how aggressive breast cancer may spread to the brain
Study shows reprogramming thyroid tumours may improve CAR-T cell therapy
Virtual biotech company puts thousands of AI scientist agents to work on drug discovery
Making invisible cancers visible: Study suggests a new route to turn ‘cold’ tumours ‘hot’
A new AI-powered test offers more accurate prediction of breast cancer recurrence risk
Middle East presence strengthened with potential blood cancer treatment, generated by AI, first of its kind in the UAE
Study identifies candidate treatment targets for high-grade glioma in children and young adults
Rare inherited EGFR mutation linked to dramatically increased lung cancer risk
The dawn of RAS-targeted therapy: a landmark breakthrough of daraxonrasib in pancreatic cancer